Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. - Wikidata - wikimedia - TriplyDB

Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper.

Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper.

http://www.wikidata.org/entity/Q46912843

about

Toxic epidermal necrolysis Management and Prevention of Anaphylaxis Sugammadex and rocuronium-induced anaphylaxis Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management.Impact of high serum Immunoglobulin E levels on the risk of atherosclerosis in humans.Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement Anaesthesia-associated hypersensitivity reactions: seven years' data from a British bi-specialty clinic.Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis.Diagnosis and management of immediate hypersensitivity reactions to cephalosporins.Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergolo Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage.Chlorpheniramine-induced anaphylaxis diagnosed by basophil activation test Management of drug hypersensitivity in the pediatric population.International survey on skin patch test procedures, attitudes and interpretation.Knowledge, attitudes, and practices survey of drug allergy among healthcare practitioners in central China: a multicenter study.Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone.The Basophil Activation Test Is Safe and Useful for Confirming Drug-Induced Anaphylaxis Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity.Recurrent intradialytic heparin induced anaphylaxis: workup and management.Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?Prediction of hypersensitivity to antibiotics: what factors need to be considered?Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.Evaluation of antibiotic allergy: the role of skin tests and drug challenges.Update on skin allergy.The diagnosis and management of antibiotic allergy in children: Systematic review to inform a contemporary approach.Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis.Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper.Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.Perioperative anaphylaxis: what should be known?The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group.Adverse cutaneous drug eruptions: current understanding.The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.Anaphylaxis during general anaesthesia: experience from a drug allergy centre in the UK.Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.Recent advances in the understanding of severe cutaneous adverse reactions.

P2860

Q26745232-3B973899-3442-4FF1-92E8-47945AFFB2E9 Q26766190-67CCAAFF-BE13-48A8-BBC6-FFADCE14DE8B Q26773458-049668D7-72B3-4585-B5BA-C2C073125474 Q26784638-8E7C6327-1E5A-41EA-9179-BDA9CEE4FCEC Q28547386-15B054B9-A626-490C-8D9A-2C7926F46770 Q30240144-504E1786-51F0-4B9D-A43D-788805CBE543 Q30356968-86660A94-4CCE-4A01-BB0C-374DFF60852D Q30371972-A5F8561E-62DD-40DB-8E4F-8078D9B32F1A Q31023298-B70AC582-3881-48B7-B0CE-A751E99ACC4F Q33734529-F1F41DA0-42A4-4EBE-B34C-58A25ED4E773 Q34429676-32AC9C76-AB9A-4FAC-B6C1-B25FC6A6F72C Q35777131-60E060A5-0691-41EA-B486-BB4685139A6A Q35779747-C040C949-483C-4F5B-B5AA-0BC329EA7D7D Q35905742-3819AF21-8536-4C8A-A537-FD95920F6F8F Q36078721-F43B3412-A886-42F0-A4A4-D7F7E58E628C Q36651675-727BC3BA-8B19-454B-A474-25C8AC87CDE8 Q36850154-371CB82F-30C6-4F4F-A550-57BF4BA384C5 Q37003616-FBE3794A-9D4B-42C7-91C4-8878ECB6D23D Q37231367-7D3D4600-9A59-4A45-82EB-88D1D436F024 Q37305124-B16C200B-D06A-4B9F-B8E3-3CF7339D49D4 Q37305136-2E066259-01C6-4A4C-B274-7DD3D1E78AEC Q37695437-62C12CA1-6096-4DA4-A277-4F11E7B9FEC2 Q37729070-3C03E7D2-AFA2-40E9-AEAB-A3D711AD4770 Q38161564-6CF76692-9C9F-4DB2-8415-6CDF11996E38 Q38222050-CB30BBC7-54E3-48CA-A9BC-E75D865F2E28 Q38233315-51D43970-7D92-4017-8D24-01780B630DEC Q38241731-E8EC36F4-AB25-4EDE-A4FE-B7CEC37F6141 Q38256777-3C1A7D00-5B17-46A2-AF8A-E23410CAF3E3 Q38295242-D4DEFD20-A91D-48A7-8EB4-FFF9293149A4 Q38343365-C229CB19-D150-4F71-BFF2-729B17B31998 Q38396594-CE40245D-57FE-4BBE-BCAC-E6D282D0FE25 Q38541188-5DA2FF60-8DE2-4470-844D-D9E38AEAB26E Q38542312-24056391-3C20-4C3C-A2DB-712718C13075 Q38551689-8B9B5640-7A66-416F-B662-694049489CCB Q38594812-B74BCAD2-4BB5-4D91-8F74-1A93108E9112 Q38629246-572664CF-1926-48EE-8576-FC58ABAD4093 Q38637036-757F0DB5-B79D-4408-AAC5-4C8C098A4547 Q38761189-11F634C5-F642-42B4-9025-F075521DD349 Q38805641-2F43A480-2FA7-4D0C-9213-1315DD00EC74 Q38931289-E3212CEE-33E1-41F9-A3B1-C7BAB35D2C58

P2860

Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper.

http://www.wikidata.org/entity/Q46912843

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Skin test concentrations for s ...... Interest Group position paper.

@en

Skin test concentrations for s ...... Interest Group position paper.

@nl

type

label

Skin test concentrations for s ...... Interest Group position paper.

@en

Skin test concentrations for s ...... Interest Group position paper.

@nl

prefLabel

Skin test concentrations for s ...... Interest Group position paper.

@en

Skin test concentrations for s ...... Interest Group position paper.

@nl

P1433

Q46912843-6CE2EC5E-9C71-4682-8F48-57345C090D0F

P1476

Q46912843-F158F971-E10D-4B4C-8FC0-1FD3BF0CF73F

P2093

Q46912843-00AD9670-E440-4414-8ED7-D96D5215357C

Q46912843-12765768-AE62-4F07-AB6B-B32A68E5D0B0

Q46912843-30487938-BE76-4E4A-B15A-25F6A27FC8B4

Q46912843-3261A55B-9279-4E65-B3EB-D5D12BC17808

Q46912843-454D189C-36BE-4DEB-BFA8-0A813A25CF06

Q46912843-4635B7E6-E264-4089-A69E-609B42CA9D42

Q46912843-4A3DA2D8-C212-4162-AF15-C7D82A8B1E51

Q46912843-52057174-482A-4F57-B082-62A43D7850F3

Q46912843-58D97AAF-0EAD-418A-BB17-1AA505B64D28

Q46912843-63C0B917-410F-42D2-A333-590895F86026

P2860

Q46912843-01224382-18C2-4A28-B0D7-0546956E60D2

Q46912843-04AF66DC-7D20-4C1B-B3D9-B2747372B363

Q46912843-073A3E21-BA6D-421D-B6EE-589F49FDBA58

Q46912843-0991BC76-C464-459B-9C6B-B25FAC42482A

Q46912843-0B55D25D-6EF5-4532-9980-D15EB9453540

Q46912843-0D8BFCD9-62C8-4ECC-9231-4C2A89A9B8E7

Q46912843-1F98C470-4FC9-4C98-B939-698783A0E3FE

Q46912843-31E74379-B7F1-4F6D-A932-77B25377CBCF

Q46912843-370B5BEA-4B31-476A-AE5C-C336CA070674

Q46912843-37499B22-E754-423F-B548-55910CCF7F3F

P304

Q46912843-1A6C5E0D-4871-4547-8D4C-13AFC10A95CA

P31

Q46912843-8C0301F2-5FCF-4495-8B42-9C5294D1AF98

P356

Q46912843-31E425B5-B748-4D87-83CA-F86E817B5745

P433

Q46912843-DB4409A2-CC57-4257-97B6-FBA36C2C704F

P478

Q46912843-39541529-62CA-4763-9D43-7BFD323C25CC

P50

Q46912843-91FD41DB-1BE2-4AE4-9E18-31E71AF5B895

P577

Q46912843-C17B8BE0-3CB5-463D-A08F-E8D1A8723E5E

P5875

Q46912843-155BB665-68C2-4FF3-9725-FF52F6DD0F70

P698

Q46912843-88B45A67-B9B6-453B-A0E0-931844E4F8E4

P356

P1433

P1476

Skin test concentrations for s ...... Interest Group position paper.

@en

P2093

A Barbaud

http://www.w3.org/2001/XMLSchema#string

A Bircher

http://www.w3.org/2001/XMLSchema#string

A M Chiriac

http://www.w3.org/2001/XMLSchema#string

A Romano

http://www.w3.org/2001/XMLSchema#string

A Trautmann

http://www.w3.org/2001/XMLSchema#string

B Bonadonna

http://www.w3.org/2001/XMLSchema#string

B Schnyder

http://www.w3.org/2001/XMLSchema#string

C Lombardo

http://www.w3.org/2001/XMLSchema#string

E Castro

http://www.w3.org/2001/XMLSchema#string

ENDA/EAACI Drug Allergy Interest Group

http://www.w3.org/2001/XMLSchema#string

P2860

Grading quality of evidence and strength of recommendations

Self-reported drug allergy in a general adult Portuguese population

Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions

Management of hypersensitivity reactions to iodinated contrast media

IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market

Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options.

Delayed hypersensitivity to corticosteroids in a series of 315 patients: clinical data and patch test results.

Anaphylaxis during anesthesia in France: an 8-year national survey.

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*.

Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions.

P304

702-712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.12142

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262043317

http://www.w3.org/2001/XMLSchema#string

P698

23617635

http://www.w3.org/2001/XMLSchema#string